公开(公告)号：US20180042905A1

公开(公告)日：2018-02-15

申请号：US15689985

申请日：2017-08-29

Applicant: Gilead Sciences, Inc.

Inventor： Esmeralda Aguayo ,  Todd Appleby ,  Gabriel Birkus ,  Guofeng Cheng ,  David Dornan ,  Tetsuya Kobayashi ,  Christopher Charles Mello ,  Uli Schmitz ,  Madeleine Willkom ,  Mei Yu

IPC: A61K31/44 ,  A61K45/06

CPC classification number: A61K31/44 ,  A61K31/4418 ,  A61K45/06

Abstract: The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.

公开(公告)号：US20160303095A1

公开(公告)日：2016-10-20

申请号：US15098112

申请日：2016-04-13

Applicant: Gilead Sciences, Inc.

Inventor： Esmeralda Aguayo ,  Todd Appleby ,  Gabriel Birkus ,  Guofeng Cheng ,  David Dornan ,  Tetsuya Kobayashi ,  Christopher Charles Mello ,  Uli Schmitz ,  Madeleine Willkom ,  Mei Yu

IPC: A61K31/44 ,  A61K45/06

CPC classification number: A61K31/44 ,  A61K31/4418 ,  A61K45/06

Abstract: The present invention relates to novel methods of treating Hepatitis B Virus by administering a KDM5 inhibitor.

Abstract translation: 本发明涉及通过施用KDM5抑制剂治疗乙型肝炎病毒的新方法。